Travel Medicine

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA Alert
fda alert
FDA Alert
FDA Approves Liver-Directed Treatment for Adults With Metastatic Uveal Melanoma
09/11/2023
Anthony Calabro, MA
The FDA approval follows a single-arm, multicenter, open-label trial in 91 patients with uveal melanoma with unresectable hepatic metastases.
09/11/2023
FDA alert
fda alert
FDA alert
New Treatment for Certain Bacterial Pneumonia Approved by FDA
08/25/2023
Jessica Ganga
Following a multicenter clinical trial, a new treatment for pneumonia caused by Acinetobacter baumannii-calcoaceticus has been approved for use in adults.
08/25/2023
FDA alert
fda alert
FDA alert
New Treatment for Certain Bacterial Pneumonia Approved by FDA
08/25/2023
Jessica Ganga
Following a multicenter clinical trial, a new treatment for pneumonia caused by Acinetobacter baumannii-calcoaceticus has been approved for use in adults.
08/25/2023
FDA alert
fda alert
FDA alert
New Treatment for Certain Bacterial Pneumonia Approved by FDA
08/25/2023
Jessica Ganga
Following a multicenter clinical trial, a new treatment for pneumonia caused by Acinetobacter baumannii-calcoaceticus has been approved for use in adults.
08/25/2023
FDA alert
fda alert
FDA alert
New Treatment for Certain Bacterial Pneumonia Approved by FDA
08/25/2023
Jessica Ganga
Following a multicenter clinical trial, a new treatment for pneumonia caused by Acinetobacter baumannii-calcoaceticus has been approved for use in adults.
08/25/2023
FDA alert
fda alert
FDA alert
New Treatment for Certain Bacterial Pneumonia Approved by FDA
08/25/2023
Jessica Ganga
Following a multicenter clinical trial, a new treatment for pneumonia caused by Acinetobacter baumannii-calcoaceticus has been approved for use in adults.
08/25/2023
FDA alert
fda alert
FDA alert
New Treatment for Certain Bacterial Pneumonia Approved by FDA
08/25/2023
Jessica Ganga
Following a multicenter clinical trial, a new treatment for pneumonia caused by Acinetobacter baumannii-calcoaceticus has been approved for use in adults.
08/25/2023
FDA Alert
fda
FDA Alert
FDA Approves First RSV Vaccine For Pregnant Individuals
08/24/2023
Anthony Calabro, MA
Earlier this year, the FDA approved the same vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.
08/24/2023
FDA Alert
fda
FDA Alert
FDA Approves First RSV Vaccine For Pregnant Individuals
08/24/2023
Anthony Calabro, MA
Earlier this year, the FDA approved the same vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.
08/24/2023
FDA Alert
fda
FDA Alert
FDA Approves First RSV Vaccine For Pregnant Individuals
08/24/2023
Anthony Calabro, MA
Earlier this year, the FDA approved the same vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.
08/24/2023